158 related articles for article (PubMed ID: 35183572)
1. Comparison of gene fusion detection methods in salivary gland tumors.
Sun L; Petrone JS; McNulty SN; Evenson MJ; Zhu X; Robinson JA; Chernock RD; Duncavage EJ; Pfeifer JD
Hum Pathol; 2022 May; 123():1-10. PubMed ID: 35183572
[TBL] [Abstract][Full Text] [Related]
2. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
[TBL] [Abstract][Full Text] [Related]
3. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
5. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
6. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
[TBL] [Abstract][Full Text] [Related]
7. Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay.
Lanic MD; Guérin R; Wassef M; Durdilly P; Rainville V; Sater V; Jardin F; Ruminy P; Costes-Martineau V; Laé M
Histopathology; 2023 Nov; 83(5):685-699. PubMed ID: 37350081
[TBL] [Abstract][Full Text] [Related]
8. The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.
Kaur K; Mehta S; Vanik S; Trivedi P; Banerjee N; Dhar H; Datta S; Karanjai S
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3769-3783. PubMed ID: 35267084
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms.
Darras N; Mooney KL; Long SR
J Am Soc Cytopathol; 2019; 8(3):157-164. PubMed ID: 31097292
[TBL] [Abstract][Full Text] [Related]
10. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
11. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
Fehr A; Stenman G; Bullerdiek J; Löning T
Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
[TBL] [Abstract][Full Text] [Related]
12. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
[TBL] [Abstract][Full Text] [Related]
13. Cystic Salivary Gland Neoplasms: Diagnostic Approach With a Focus on Ancillary Studies.
Ribeiro EA; Maleki Z
Adv Anat Pathol; 2022 Nov; 29(6):365-372. PubMed ID: 36044380
[TBL] [Abstract][Full Text] [Related]
14. Cytopathologic features of mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista DA; Westra WH; Ali SZ
Cancer Cytopathol; 2013 May; 121(5):228-33. PubMed ID: 23042752
[TBL] [Abstract][Full Text] [Related]
15. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
[TBL] [Abstract][Full Text] [Related]
16. Use of fluorescent in-situ hybridisation in salivary gland cytology: A powerful diagnostic tool.
Evrard SM; Meilleroux J; Daniel G; Basset C; Lacoste-Collin L; Vergez S; Uro-Coste E; Courtade-Saidi M
Cytopathology; 2017 Aug; 28(4):312-320. PubMed ID: 28503786
[TBL] [Abstract][Full Text] [Related]
17. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
[TBL] [Abstract][Full Text] [Related]
19. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization.
Hudson JB; Collins BT
Arch Pathol Lab Med; 2014 Mar; 138(3):403-9. PubMed ID: 24576033
[TBL] [Abstract][Full Text] [Related]
20. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
Stenman G
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]